| Karen M Liepke, RN, CDE | |
|
1102 Main St, Williston, ND 58801-4233 | |
| (701) 572-7711 | |
| (701) 572-0566 |
| Full Name | Karen M Liepke |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Diabetes Educator |
| Location | 1102 Main St, Williston, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861534919 | NPI | - | NPPES |
| 19491 | Other | ND | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WD0400X | Registered Nurse - Diabetes Educator | R17752 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen M Liepke, RN, CDE 1102 Main St, Williston, ND 58801-4233 Ph: (701) 572-7711 | Karen M Liepke, RN, CDE 1102 Main St, Williston, ND 58801-4233 Ph: (701) 572-7711 |
News Archive
Young Black women show a high prevalence of obesity, elevated blood pressure and other lifestyle-related factors that may put them on a trajectory to develop heart disease at a young age, according to a study presented at the American College of Cardiology's 70th Annual Scientific Session.
In March 2020, New York City, an icon of America, was unfortunately named an early epicenter of the novel coronavirus. Now seven months later, America faces a new surge in coronavirus cases and researchers at Texas A&M University hope to provide information and context to help with the battle ahead.
Barrett's oesophagus is a metaplastic disorder that develops in about 10% of people with chronic gastro-oesophageal reflux disease. Every year about 0.5%-1% of patients with Barrett's oesophagus develop oesophageal adenocarcinoma.
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
› Verified 1 days ago
Karen L. Johnson, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1321 W Dakota Pkwy, Williston, ND 58801 Phone: 701-572-7711 | |
Elizabeth Boots, RN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 316 2nd Ave W, Williston, ND 58801 Phone: 701-774-4600 Fax: 701-774-4620 | |
Janet Williams, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1301 15th Ave W, Williston, ND 58801 Phone: 701-774-7400 | |
Ms. Angela R Ekblad, NP/RN Registered Nurse Medicare: Medicare Enrolled Practice Location: 3 4th Street East, Williston, ND 58801 Phone: 701-847-3771 Fax: 701-842-4025 | |
Priscilla Marie Otto, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1102 7th Ave E, Williston, ND 58801 Phone: 701-572-7262 | |
Mckenzie Larae Moor, PMHNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1500 14th St W, Williston, ND 58801 Phone: 701-572-3335 Fax: 701-572-3337 | |
Katelyn Marie Sandberg, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 316 2nd Ave W, Williston, ND 58801 Phone: 701-774-4631 |